Abstract:Lactoferricin B (LfcinB), a 25 residue peptide derived from the N-terminal of bovine lactoferrin (bLF), causes depolarization of the cytoplasmic membrane in susceptible bacteria. Its mechanism of action, however, still needs to be elucidated. In the present study, synthetic LfcinB (without a disulfide bridge) and LfcinB (C–C; with a disulfide bridge) as well as three derivatives with 15-, 11- and 9-residue peptides were prepared to investigate their antimicrobial nature and mechanisms. The antimicrobial properties were measured via minimum inhibitory concentration (MIC) determinations, killing kinetics assays and synergy testing, and hemolytic activities were assessed by hemoglobin release. Finally, the morphology of peptide-treated bacteria was determined by atomic force microscopy (AFM). We found that there was no difference in MICs between LfcinB and LfcinB (C–C). Among the derivatives, only LfcinB15 maintained nearly the same level as LfcinB, in the MIC range of 16–128 μg/ml, and the MICs of LfcinB11 (64–256 μg/ml) were 4 times more than LfcinB, while LfcinB9 exhibited the lowest antimicrobial activity. When treated at MIC for 1 h, many blebs were formed and holes of various sizes appeared on the cell surface, but the cell still maintained its integrity. This suggested that LfcinB had a major permeability effect on the cytoplasmic membrane of both Gram-positive and Gram-negative bacteria, which also indicated it may be a possible intracellular target. Among the tested antibiotics, aureomycin increased the bactericidal activity of LfcinB against E. coli, S. aureus and P. aeruginosa, but neomycin did not have such an effect. We also found that the combination of cecropin A and LfcinB had synergistic effects against E. coli.

Current Status and Future Prospects of Bovine Lactoferricin

Review on Progress of Bovine Lactoferricin and Its Derivatives Peptides

Advances on the Bio-activities of Lactoferricin and its Application

A Review of the Structure and Activity of Lactoferricin

Comparative Antimicrobial Activity and Mechanism of Action of Bovine Lactoferricin-Derived Synthetic Peptides

Design of bovine lactoferricin-derived peptide and its expression and activity in Pichia pastoris

Improved Antimicrobial Activity of Bovine Lactoferrin Peptide (lfcinb) Based on Rational Design

Progress of Study on Lactoferricin

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Expression of Recombinant Porcine Lactoferrin N-lobe in Pichia Methanolica and Its Antibacterial Activity

Lactoferricin, an antimicrobial motif derived from lactoferrin with food preservation potential

Fusion Expression of Bovine Lactoferricin in Escherichia Coli

Recent Development of Lactoferrin (its Active Peptides and Their Physiological Functions II)

Expression, Purification, and Antibacterial Activity of Bovine Lactoferrampin–Lactoferricin in Pichia pastoris

Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences.

Lactoferrin and Peptide-derivatives: Antimicrobial Agents with Potential Use in Nonspecific Immunity Modulation

Research Status and Prospect of Lactoferrin

Current Advances in Production and Drying Technologies of Lactoferrin

Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli

A Review on cLF36, a Novel Recombinant Antimicrobial Peptide-Derived Camel Lactoferrin

Prokaryotic Expression and Antibiotic Activity of Recombinant Bovine Lactoferricin Fusion Protein